Mckesson Medical-Surgical Inc. Corporate Office: Drug Recall

Recall #D-1324-2022 · 06/29/2022

Class II: Risk

Recall Details

Recall Number
D-1324-2022
Classification
Class II
Product Type
Drug
Recalling Firm
Mckesson Medical-Surgical Inc. Corporate Office
Status
Terminated
Date Initiated
06/29/2022
Location
Richmond, VA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1 box

Reason for Recall

CGMP Deviations: products were stored outside the drug label specifications.

Product Description

Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.

Distribution Pattern

Nationwide in the USA.

Other Recalls by Mckesson Medical-Surgical Inc. Corporate Office

View all recalls by Mckesson Medical-Surgical Inc. Corporate Office →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.